Emergency Medicine Certificate

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity is intended for pharmacists interested in expanding their knowledge and skills related to pharmacy practice in emergency medicine.

The Pharmacist's Role in Emergency Medicine
0204-0000-22-773-H04-P

• Describe the services and activities that pharmacists can perform when caring for patients in the emergency department.
• Compare techniques to complete medication histories and reconciliations.
• Apply principles of medication safety and risk mitigation strategies to the emergency department.
• Identify opportunities for pharmacy involvement in prehospital activities.
• Evaluate the use of clinical information provided by Emergency Medical Services personnel.
• Describe the role of pharmacy personnel in disaster preparedness and response.

Trauma, Hemostasis, and Life Support
0204-0000-22-774-H01-P

• Discuss the role of the pharmacist when caring for patients with traumatic injuries.
• Recommend appropriate treatment for common injuries in trauma.
• Propose evidence-based resuscitation therapies for patients with burn injuries.
• Outline appropriate therapies for hemostasis in trauma patients. 
• Propose evidence-based anticoagulation reversal recommendations for patients presenting with hemorrhage.
• Identify the core elements of basic life support and advanced life support.
• Define the pharmacist’s role in the care of pediatric and adult patients requiring advanced life support.
• Apply treatment algorithms for adult and pediatric life support.

Shock States
0204-0000-22-775-H01-P

• Differentiate among hypovolemic, distributive, obstructive, and cardiogenic shock.
• Compare the distribution patterns of hypotonic, isotonic, and hypertonic fluids.
• Describe the anticipated physiologic effects of commonly used vasopressors and inotropic agents.
• Construct a therapeutic plan for patients suffering from common shock states.
• Differentiate between sepsis and septic shock.
• Describe goals of therapy for a patient with sepsis or septic shock.
• Apply a treatment plan for a patient with sepsis or septic shock. 

Cardiovascular and Pulmonary Emergencies
0204-0000-22-776-H01-P

• Analyze clinical presentations of hypertensive emergencies.
• Describe pharmacotherapeutic priorities when managing patients with acute coronary syndromes.
• Assess therapeutic options for a patient with acute pulmonary edema.
• Differentiate among therapeutic options for the management of heart failure exacerbations.
• Compare the different therapeutic alternatives for the management of atrial fibrillation.
• Recognize challenges in the treatment of supraventricular tachycardia.
• Identify opportunities to develop outpatient management strategies for patients with dysrhythmias.
• Assess a patient case to determine appropriate treatment for venous thromboembolism.
• Compare and contrast efficacy and toxicity of pharmacologic treatments for asthma exacerbation.
• Choose the most appropriate treatment for a patient experiencing chronic obstructive pulmonary disease exacerbation. 

Infectious Diseases
0204-0000-22-777-H01-P

• Recognize the roles of an emergency department pharmacist as an antimicrobial steward.
• Identify common pathogens associated with pneumonia.
• Apply evidence-based guidelines to guide antimicrobial therapy for pneumonia.
• Recommend appropriate antibiotic regimens for meningitis.
• Compare and contrast the various classifications of urinary tract infections.
• Select the most appropriate treatment for urinary tract infections based on diagnosis and suspected pathogens.
• Recommend appropriate treatment options for common sexually transmitted infections.
• Recognize when antibiotic therapy is clinically indicated for skin and soft tissue infections.
• Assess the appropriateness of antibiotic regimens for skin and soft tissue infections.
• Select the most appropriate antibiotic therapy based on severity of intra-abdominal infection.
• Evaluate the appropriateness of a one-time intravenous dose of antibiotics before discharge.
• Discuss appropriate durations of antimicrobial therapy for common infections.

Neurologic and Psychiatric Emergencies
0204-0000-22-778-H01-P

• Compare and contrast efficacy and toxicity of pharmacologic treatments for migraine.
• Recommend therapeutic options for acute ischemic stroke.
• Apply evidence based guidelines to determine appropriate candidates for tissue plasminogen activator therapy.
• Describe evidence-based treatment options for seizures.
• Recognize the most appropriate medication to utilize for management of acute agitation.
• Select the most appropriate therapy for an alcohol withdrawal patient.

Pain, Sedation, and Neuromuscular Blockade
0204-0000-22-779-H01-P

• Describe the diverse types of pain and pain syndromes encountered in the emergency department.
• Compare non-opioid analgesic strategies for the treatment of pain.
• Analyze prescribing practices for opioids in the emergency department and at discharge to minimize misuse and abuse.
• Apply knowledge of rapid sequence intubation and therapies involved to provide optimal pharmacotherapy.
• Identify the most appropriate analagosedation treatment plan for a patient following rapid sequence intubation.
• Differentiate among pharmacotherapy options for procedural sedation.

Acid-Base & Electrolyte Disorders and Oncologic  & Hematologic Emergencies
0204-0000-22-780-H01-P

• List common electrolyte disturbances found in patients presenting to the emergency department.
• Design treatment plans for patients presenting with hyponatremia and hypernatremia.
• Describe therapeutic options for patients with hyperkalemia.
• Differentiate characteristics of metabolic acidosis and alkalosis and compensatory mechanisms.
• Given a scenario, select the most appropriate treatment for specific oncologic and hematologic emergencies.

Gastrointestinal and Renal Emergencies
0204-0000-22-781-H01-P

• Compare common etiologies for nausea that may present in the emergency department and specific treatments associated with each.
• Construct an initial pharmaceutical treatment plan for a patient with acute variceal bleeding.
• Select appropriate empiric antibiotics for patients diagnosed with acute appendicitis and acute cholecystitis.
• Identify supportive pharmaceutical treatment for patients presenting in acute liver failure.
• Develop a treatment plan for a patient with acute pain from nephrolithiasis.
• Identify medications used in the emergency department with potential to cause acute kidney injury.
• Analyze medication orders to determine required dose adjustments in a patient with acute kidney injury.

Endocrine and Dermatologic Emergencies
0204-0000-22-782-H01-P

• Discuss presentations and therapies for the management of myxedema coma and thyrotoxicosis.
• Design pharmacotherapy regimens and monitoring plans for the treatment of diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome.
• Apply appropriate treatment strategies for adrenal emergencies.
• Compare clinical and laboratory findings for Stevens Johnson Syndrome, Toxic Epidermal Necrolysis, Necrotizing Fasciitis, and Rocky Mountain Spotted Fever.
• Describe the goals of care for a patient presenting with a dermatologic emergency. 

Toxicology and Special Populations
0204-0000-22-783-H01-P

• Explain the general approach to managing a poisoned patient.
• Describe methods of gastrointestinal decontamination.
• Compare and contrast common toxidromes.
• List common antidotes used for the management of overdose patients.
• Explain how to effectively administer hyperinsulinemia-euglycemia therapy in the overdose patient.
• Calculate an appropriate digoxin immune fab dose for a digoxin toxic patient.
• Recommend a treatment plan to manage toxicity resulting from an unknown cardiovascular toxicant.
• Describe the therapeutic endpoints when managing an acetaminophen overdose.
• Analyze laboratory results to appropriately stage a salicylate toxic patient.
• Describe general approaches for pharmacologic treatment of pediatric patients.
• Identify appropriate treatment plans for obstetric emergencies.
• Assess how the pharmacologic needs of geriatric patients differ from other populations.

Learning Activity	ACPE Number	Contact Hours
The Pharmacist’s Role in Emergency Medicine	0204-0000-22-773-H04-P	2.5
Trauma, Hemostasis, and Life Support	0204-0000-22-774-H01-P	3.0
Shock States	0204-0000-22-775-H01-P	2.25
Cardiovascular and Pulmonary Emergencies	0204-0000-22-776-H01-P	3.5
Infectious Diseases	0204-0000-22-777-H01-P	2.5
Neurologic and Psychiatric Emergencies	0204-0000-22-778-H01-P	2
Pain, Sedation, and Neuromuscular Blockade	0204-0000-22-779-H01-P	3
Acid-Base & Electrolyte Disorders and Oncologic & Hematologic Emergencies	0204-0000-22-780-H01-P	2
Gastrointestinal and Renal Emergencies	0204-0000-22-781-H01-P	1.5
Endocrine and Dermatologic Emergencies	0204-0000-22-782-H01-P	2
Toxicology and Special Populations	0204-0000-22-773-H04-P	3.25
→  Final Assessment (80% passing score required)

Kristin Bohnenberger, Pharm.D., DABAT
Clinical Assistant Professor
Ernest Mario School of Pharmacy at Rutgers
The State University of New Jersey
Piscataway, New Jersey
Clinical Pharmacist – Emergency Medicine
Penn Medicine Princeton Medical Center
Plainsboro, New Jersey

Daniel H. Jarrell, Pharm.D., BCCCP, BCPS
Clinical Pharmacy Specialist - Emergency Medicine
Program Director - PGY2 Emergency Medicine
Banner - University Medical Center Tucson
Tucson, Arizona

Patrick J. Bridgeman, Jr. Pharm.D., BCPS
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Piscataway, New Jersey
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Megan Corrigan, Pharm.D., M.P.H., BCPS
Clinical Pharmacy Manager
Advocate Good Samaritan Hospital
Downers Grove, Illinois

Katelyn R. Dervay, Pharm.D., M.P.H., BCPS, FASHP
Pharmacotherapy Specialist - Emergency Medicine;
Director, PGY2 Emergency Medicine Residency
Tampa General Hospital
Tampa, Florida

Christopher J. Edwards, Pharm.D., BCPS
Assistant Professor
University of Arizona College of Pharmacy
Tucson, Arizona

Brett Faine, Pharm.D., M.S.
Clinical Assistant Professor
Emergency Medicine Clinical Pharmacy Specialist
University of Iowa College of Pharmacy
Carver College of Medicine
Iowa City, Iowa

Ayumi Tran, Pharm.D., BCPS
Emergency Medicine Clinical Pharmacist
Advocate Good Samaritan Hospital
Downers Grove, Illinois

Kyle A. Weant, Pharm.D., BCCCP, BCPS, FCCP
Clinical Assistant Professor
Department of Clinical Pharmacy and Outcomes Sciences\
University of South Carolina College of Pharmacy
Columbia, South Carolina

Anne Zepeski, Pharm.D., BCPS
Clinical Pharmacist, Emergency Medicine
University of Iowa Hospitals and Clinics
Iowa City, Iowa

David E. Zimmerman, Pharm.D., BCCCP
Associate Professor of Pharmacy
Duquesne University School of Pharmacy
Emergency Medicine Pharmacist
University of Pittsburgh Medical Center-Mercy Hospital
Pittsburgh, Pennsylvania

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

As required by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company, all relevant financial relationships have been mitigated prior to the CPE activity.